(FNF) Fidelity National Financial - Overview
Sector: Financial Services | Industry: Insurance - Specialty | Exchange: NYSE (USA) | Market Cap: 13.326m USD | Total Return: -1.1% in 12m
Avg Turnover: 73.8M
EPS Trend: 93.7%
Qual. Beats: -1
Rev. Trend: 94.8%
Qual. Beats: -1
Warnings
No concerns identified
Tailwinds
No distinct edge detected
Fidelity National Financial, Inc. (FNF) is a leading provider of title insurance and transaction services for the real estate and mortgage industries in the United States. The company operates through three primary segments: Title, F&G, and Corporate. Its core business involves issuing title insurance policies, escrow services, and home warranties, alongside mortgage technology and real estate brokerage operations.
The company also maintains a significant presence in the life insurance and retirement sectors through its F&G segment. This division offers fixed indexed annuities, universal life insurance, and pension risk transfer solutions. Title insurance is a specialized branch of the insurance industry where premiums are typically paid as a one-time fee at closing to protect against past defects in property titles, rather than ongoing risks.
Fidelity National Financial’s business model benefits from vertical integration, providing both the software used by mortgage originators and the insurance products required to finalize property transfers. Analyzing historical performance trends on ValueRay can provide deeper insights into how these segments interact. The company is headquartered in Jacksonville, Florida, and functions as a key infrastructure provider for the U.S. residential and commercial real estate markets.
- Mortgage interest rate fluctuations dictate residential real estate transaction and title volumes
- F&G annuity sales growth provides counter-cyclical revenue diversification through investment spreads
- Housing inventory shortages limit title insurance premiums from residential resale markets
- Higher treasury yields increase investment income on title escrow and insurance float
- Commercial real estate market recovery drives high-margin title and escrow service fees
| Net Income: 762.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.01 > 0.02 and ΔFCF/TA -0.44 > 1.0 |
| NWC/Revenue: 18.43% < 20% (prev 308.2%; Δ -289.7% < -1%) |
| CFO/TA 0.05 > 3% & CFO 5.95b > Net Income 762.0m |
| Net Debt (-6.89b) to EBITDA (2.92b): -2.36 < 3 |
| Current Ratio: 60.33 > 1.5 & < 3 |
| Outstanding Shares: last quarter (269.0m) vs 12m ago -1.47% < -2% |
| Gross Margin: 74.15% > 18% (prev 0.63%; Δ 7.35k% > 0.5%) |
| Asset Turnover: 14.24% > 50% (prev 13.02%; Δ 1.22% > 0%) |
| Interest Coverage Ratio: 8.33 > 6 (EBITDA TTM 2.92b / Interest Expense TTM 243.0m) |
| A: 0.02 (Total Current Assets 2.77b - Total Current Liabilities 46.0m) / Total Assets 110b |
| B: 0.05 (Retained Earnings 5.59b / Total Assets 110b) |
| C: 0.02 (EBIT TTM 2.02b / Avg Total Assets 104b) |
| D: 0.04 (Book Value of Equity 3.69b / Total Liabilities 101b) |
| Altman-Z'' = 0.50 = B |
| DSRI: 0.02 (Receivables 308.0m/15.2b, Revenue 14.8b/12.8b) |
| GMI: 0.85 (GM 74.15% / 62.68%) |
| AQI: 2.21 (AQ_t 0.97 / AQ_t-1 0.44) |
| SGI: 1.16 (Revenue 14.8b / 12.8b) |
| TATA: -0.05 (NI 762.0m - CFO 5.95b) / TA 110b) |
| Beneish M = -3.19 (Cap -4..+1) = AA |
As of May 24, 2026, the stock is trading at USD 49.36 with a total of 1,008,954 shares traded.
Over the past week, the price has changed by +1.42%,
over one month by -3.99%,
over three months by -3.70% and
over the past year by -1.14%.
Fidelity National Financial has received a consensus analysts rating of 4.25. Therefore, it is recommended to buy FNF.
- StrongBuy: 2
- Buy: 1
- Hold: 1
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 63.3 | 28.1% |
P/E Forward = 8.2988
P/S = 0.8905
P/B = 1.7784
P/EG = 0.8538
Revenue TTM = 14.8b USD
EBIT TTM = 2.02b USD
EBITDA TTM = 2.92b USD
Long Term Debt = 4.40b USD (from longTermDebt, last quarter)
Short Term Debt = 130.0m USD (from shortTermDebt, last fiscal year)
Debt = 5.14b USD (from shortLongTermDebtTotal, last quarter) + Leases 367.0m
Net Debt = -6.89b USD (calculated: Debt 5.14b - CCE 12.0b)
Enterprise Value = 6.44b USD (13.3b + Debt 5.14b - CCE 12.0b)
Interest Coverage Ratio = 8.33 (Ebit TTM 2.02b / Interest Expense TTM 243.0m)
EV/FCF = 4.01x (Enterprise Value 6.44b / FCF TTM 1.61b)
FCF Yield = 24.94% (FCF TTM 1.61b / Enterprise Value 6.44b)
FCF Margin = 10.85% (FCF TTM 1.61b / Revenue TTM 14.8b)
Net Margin = 5.15% (Net Income TTM 762.0m / Revenue TTM 14.8b)
Gross Margin = 74.15% ((Revenue TTM 14.8b - Cost of Revenue TTM 3.83b) / Revenue TTM)
Gross Margin QoQ = none% (prev none%)
Tobins Q-Ratio = 0.06 (Enterprise Value 6.44b / Total Assets 110b)
Interest Expense / Debt = 4.73% (Interest Expense 243.0m / Debt 5.14b)
Taxrate = 35.28% (175.0m / 496.0m)
NOPAT = 1.31b (EBIT 2.02b * (1 - 35.28%))
Current Ratio = 0.82 (Total Current Assets 2.77b / Total Current Liabilities 3.39b)
Debt / Equity = 0.71 (Debt 5.14b / totalStockholderEquity, last quarter 7.25b)
Debt / EBITDA = -2.36 (Net Debt -6.89b / EBITDA 2.92b)
Debt / FCF = -4.29 (Net Debt -6.89b / FCF TTM 1.61b)
Total Stockholder Equity = 7.73b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.73% (Net Income 762.0m / Total Assets 110b)
RoE = 9.85% (Net Income TTM 762.0m / Total Stockholder Equity 7.73b)
RoCE = 16.68% (EBIT 2.02b / Capital Employed (Equity 7.73b + L.T.Debt 4.40b))
RoIC = 1.19% (NOPAT 1.31b / Invested Capital 110b)
WACC = 5.98% (E(13.3b)/V(18.5b) * Re(7.10%) + D(5.14b)/V(18.5b) * Rd(4.73%) * (1-Tc(0.35)))
Discount Rate = 7.10% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -10.89 | Cagr: -0.33%
[DCF] Terminal Value 73.26% ; FCFF base≈1.71b ; Y1≈1.51b ; Y5≈1.24b
[DCF] Fair Price = 99.64 (EV 19.9b - Net Debt -6.89b = Equity 26.8b / Shares 269.2m; r=8.35% [WACC [floored]]; 5y FCF grow -14.12% → 2.50% )
EPS Correlation: 93.68 | EPS CAGR: 13.64% | SUE: -1.16 | # QB: -1
Revenue Correlation: 94.77 | Revenue CAGR: 10.72% | SUE: -1.01 | # QB: -1
EPS current Quarter (2026-06-30): EPS=1.40 | Chg30d=-9.76% | Revisions=-50% | Analysts=4
EPS next Quarter (2026-09-30): EPS=1.54 | Chg30d=-7.12% | Revisions=-50% | Analysts=4
EPS current Year (2026-12-31): EPS=5.36 | Chg30d=-8.81% | Revisions=-50% | GrowthEPS=+7.9% | GrowthRev=+3.8%
EPS next Year (2027-12-31): EPS=6.11 | Chg30d=-5.45% | Revisions=-50% | GrowthEPS=+13.9% | GrowthRev=+7.0%
[Analyst] Revisions Ratio: -50%